Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,716 | -40,859 | -21,384 | -10,695 | -37,034 |
| Depreciation Amortization | 654 | 503 | 321 | 154 | 317 |
| Other Working Capital | 2,941 | 7,475 | -1,624 | 1,066 | 3,224 |
| Other Operating Activity | 4,714 | 3,386 | 2,223 | 1,128 | 6,010 |
| Operating Cash Flow | $-52,407 | $-29,495 | $-20,464 | $-8,347 | $-27,483 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -414 | -342 | -227 | -200 | -229 |
| Purchase Of Investment | -77,175 | -64,531 | -35,434 | -5,980 | -77,708 |
| Sale Of Investment | 63,901 | 49,547 | 34,790 | 9,585 | 12,585 |
| Investing Cash Flow | $-13,688 | $-15,326 | $-871 | $3,405 | $-65,352 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7 | -5 | -3 | -1 | -3 |
| Common Stock Issued | 83,100 | 78,758 | 64,806 | 50 | 104,328 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -162 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 237 |
| Financing Cash Flow | $83,093 | $78,753 | $64,803 | $49 | $104,400 |
| Beginning Cash Position | 32,780 | 32,780 | 32,780 | 32,780 | 21,215 |
| End Cash Position | 49,778 | 66,712 | 76,248 | 27,887 | 32,780 |
| Net Cash Flow | $16,998 | $33,932 | $43,468 | $-4,893 | $11,565 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,407 | -29,495 | -20,464 | -8,347 | -27,483 |
| Capital Expenditure | -414 | -342 | -227 | -200 | -229 |
| Free Cash Flow | -52,821 | -29,837 | -20,691 | -8,547 | -27,712 |